Controversies in the prevention and treatment of poisonings.
D000056:Accident Prevention; D000931:Antidotes / Q000627:therapeutic use; D001241:Aspirin / Q000506:poisoning; D002614:Chelating Agents / Q000627:therapeutic use; D002648:Child; D003035:Cobalt / Q000627:therapeutic use; D003486:Cyanides / Q000506:poisoning; D004348:Drug Labeling; D004349:Drug Packaging; D006801:Humans; D006838:Hydrocarbons / Q000506:poisoning; D007486:Ipecac / Q000627:therapeutic use; D008630:Mercury Poisoning / Q000188:drug therapy; D009573:Nitrites / Q000627:therapeutic use; D010396:Penicillamine / Q000031:analogs & derivatives / Q000627:therapeutic use; D014677:Pharmaceutical Vehicles; D010830:Physostigmine / Q000627:therapeutic use; D011041:Poisoning / Q000188:drug therapy* / Q000517:prevention & control; D011188:Potassium / Q000627:therapeutic use; D012449:Safety
D000931:Antidotes; D002614:Chelating Agents; D003486:Cyanides; D006838:Hydrocarbons; D009573:Nitrites; D014677:Pharmaceutical Vehicles; D003035:Cobalt; D007486:Ipecac; D010830:Physostigmine; D010396:Penicillamine; D001241:Aspirin; D011188:Potassium